Suja Life Q2 Sales Climb 11.6%, but Full-Year Guidance Cut on Velocity Headwinds

summarizeSummary

Suja Life reported Q2 2026 net sales of $83.9M (+11.6% YoY) and Adjusted EBITDA of $14.6M (+50% YoY), but lowered its full-year revenue guidance to $367M-$371M, citing slowing velocity and competitive pressures.

check_boxKey Events · Earnings and Guidance · SUJA

• Q2 Revenue +11.6%, EBITDA +50%

  Net sales reached $83.9M, driven by 6.9% volume growth in Suja Core and 72.1% volume growth in Emerging Brands. Adjusted EBITDA rose to $14.6M, with gross margin of 46.7%.

• Full-Year Guidance Lowered

  Management now expects fiscal 2026 revenue of $367M-$371M, down from prior guidance, citing slowing velocity rates and increased competitive promotional activity expected to persist in Q3.

• Balance Sheet Strengthened Post-IPO

  Cash stands at $20.6M with total debt reduced to $164.9M after using IPO proceeds to repay $142.6M of borrowings. $40M revolving credit facility remains undrawn.

• Emerging Brands Margin Inflection

  Emerging Brands gross margin surged to 44.1% from 16.3% a year ago, driven by sourcing efficiencies and the absence of one-time startup costs, though the segment remains unprofitable at the EBITDA level.

auto_awesomeAnalysis · SUJA · Manufacturing

Suja Life delivered solid Q2 top-line growth of 11.6% to $83.9M and a 50% jump in Adjusted EBITDA to $14.6M, but management lowered its full-year revenue outlook to $367M-$371M, citing slowing velocity rates and increased competitive promotional activity. The guidance cut, coming just two months after the IPO, signals that near-term demand headwinds are more persistent than expected. While the balance sheet is stronger post-IPO with debt reduced to $164.9M and $20.6M in cash, the lowered forecast raises questions about the pace of the growth story that underpinned the May IPO.